Log In
Print
BCIQ
Print
Print this Print this
 

Oxabact

  Manage Alerts
Collapse Summary General Information
Company OxThera AB
DescriptionCapsule formulation of lyophilized live Oxalobacter formigenes
Molecular Target Not applicable
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I/II
Standard IndicationHyperoxaluria
Indication DetailsTreat primary hyperoxaluria
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today